MyFinsight
Home
About
Contact
Back
Income Statement
Estrella Immunopharma, Inc. (ESLA)
source: myfinsight.com
Download
Download image
Net loss
-$5,544,878
Loss before income
taxes
-$5,544,028
Income taxes provision
$850
Loss from operations
-$5,544,028
Total operating
expenses
$5,544,028
General and
administrative
$883,727
Research and development
$4,660,301
Back